# BEONE MEDICINES LTD. (ONC) FY2025 Annual P&L / Income Statement

- Company: BEONE MEDICINES LTD. (ONC)
- Period: 2025-01-01 to 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-26, accession number 0001628280-26-011946
- Page: https://plicit.ai/financials/onc/fy2025-annual-income-statement
- Chart image: https://plicit.ai/charts/onc-fy2025-annual-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2025-01-01 through 2025-12-31. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 5,343,033,000 US dollars
- **Cost of revenue (calculated)**: 668,540,000 US dollars
- **Gross profit**: 4,674,493,000 US dollars
- **Operating expenses (calculated)**: 4,227,357,000 US dollars
- **Income (loss) from operations**: 447,136,000 US dollars
- **Other income (expense), net (calculated)**: negative 30,282,000 US dollars
- **Income (loss) before income taxes**: 416,854,000 US dollars
- **Income tax expense**: 129,921,000 US dollars
- **Net income (loss)**: 286,933,000 US dollars
- **Other - Other**: 0 US dollars
- **Other - CHINA**: 20,168,000 US dollars
- **Other - UNITED STATES**: 39,078,000 US dollars
- **Other - Europe- total revenue**: 1,726,000 US dollars
- **Product revenue, net - Other**: 171,809,000 US dollars
- **Product revenue, net - CHINA**: 1,659,363,000 US dollars
- **Product revenue, net - UNITED STATES**: 2,841,246,000 US dollars
- **Product revenue, net - Europe- total revenue**: 609,643,000 US dollars
- **Cost of sales - product**: 668,540,000 US dollars
- **Selling, general and administrative**: 2,081,489,000 US dollars
- **Research and development**: 2,145,868,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/onc/fy2025-annual-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/onc-fy2025-annual-revenue-by-geography-sankey.png

Income statement for 2025-01-01 through 2025-12-31. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 5,343,033,000 US dollars
- **Cost of revenue (calculated)**: 668,540,000 US dollars
- **Gross profit**: 4,674,493,000 US dollars
- **Operating expenses (calculated)**: 4,227,357,000 US dollars
- **Income (loss) from operations**: 447,136,000 US dollars
- **Other income (expense), net (calculated)**: negative 30,282,000 US dollars
- **Income (loss) before income taxes**: 416,854,000 US dollars
- **Income tax expense**: 129,921,000 US dollars
- **Net income (loss)**: 286,933,000 US dollars
- **UNITED STATES**: 2,880,324,000 US dollars
- **CHINA**: 1,679,531,000 US dollars
- **Europe- total revenue**: 611,369,000 US dollars
- **Rest of world- total revenue**: 171,809,000 US dollars
- **Cost of sales - product**: 668,540,000 US dollars
- **Selling, general and administrative**: 2,081,489,000 US dollars
- **Research and development**: 2,145,868,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service

- Page: https://plicit.ai/financials/onc/fy2025-annual-income-statement/revenue-by-product-and-service
- Chart image: https://plicit.ai/charts/onc-fy2025-annual-revenue-by-product-and-service-sankey.png

Income statement for 2025-01-01 through 2025-12-31. View: Product and service. Revenue and costs use their disclosed categories.

- **Total revenues**: 5,343,033,000 US dollars
- **Cost of revenue (calculated)**: 668,540,000 US dollars
- **Gross profit**: 4,674,493,000 US dollars
- **Operating expenses (calculated)**: 4,227,357,000 US dollars
- **Income (loss) from operations**: 447,136,000 US dollars
- **Other income (expense), net (calculated)**: negative 30,282,000 US dollars
- **Income (loss) before income taxes**: 416,854,000 US dollars
- **Income tax expense**: 129,921,000 US dollars
- **Net income (loss)**: 286,933,000 US dollars
- **Product revenue, net revenue**: 5,282,061,000 US dollars
- **Other revenue**: 60,972,000 US dollars
- **Product revenue, net cost of revenue**: 668,540,000 US dollars
- **Selling, general and administrative**: 2,081,489,000 US dollars
- **Research and development**: 2,145,868,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product Name by Product and Service

- Page: https://plicit.ai/financials/onc/fy2025-annual-income-statement/revenue-by-product-name-by-product-and-service
- Chart image: https://plicit.ai/charts/onc-fy2025-annual-revenue-by-product-name-by-product-and-service-sankey.png

Income statement for 2025-01-01 through 2025-12-31. View: Product Name by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 5,343,033,000 US dollars
- **Cost of revenue (calculated)**: 668,540,000 US dollars
- **Gross profit**: 4,674,493,000 US dollars
- **Operating expenses (calculated)**: 4,227,357,000 US dollars
- **Income (loss) from operations**: 447,136,000 US dollars
- **Other income (expense), net (calculated)**: negative 30,282,000 US dollars
- **Income (loss) before income taxes**: 416,854,000 US dollars
- **Income tax expense**: 129,921,000 US dollars
- **Net income (loss)**: 286,933,000 US dollars
- **BLINCYTO - Product revenue, net**: 104,224,000 US dollars
- **BRUKINSA - Product revenue, net**: 3,928,489,000 US dollars
- **KYPROLIS - Product revenue, net**: 74,974,000 US dollars
- **Other - Product revenue, net**: 83,691,000 US dollars
- **POBEVCY - Product revenue, net**: 47,400,000 US dollars
- **Tislelizumab - Product revenue, net**: 737,304,000 US dollars
- **XGEVA - Product revenue, net**: 305,979,000 US dollars
- **Undisclosed (calculated)**: 60,972,000 US dollars
- **Cost of sales - product**: 668,540,000 US dollars
- **Selling, general and administrative**: 2,081,489,000 US dollars
- **Research and development**: 2,145,868,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.